Billiontoone (NASDAQ:BLLN) Announces Quarterly Earnings Results, Hits Estimates

Billiontoone (NASDAQ:BLLN) released its earnings results on Wednesday. The company reported $0.15 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.15, FiscalAI reports. The firm had revenue of $109.45 million during the quarter.

Here are the key takeaways from Billiontoone’s conference call:

• Q2 revenue rose 64% year over year to $109.4 million, driven by 35% test-volume growth and a 21% increase in average selling price. Oncology revenue surged 176% to $13.7 million, while prenatal revenue increased 56% to $95.8 million.
• Gross margin expanded to 70.5% from 65.3% a year earlier, while the company generated $5.5 million in GAAP operating income, a 15% adjusted EBITDA margin, and $5.1 million of free cash flow. Cash and equivalents ended the quarter at $549 million.
• BillionToOne highlighted several growth catalysts, including strong early adoption of Unity Confirm, the upcoming 130-gene Fetal Risk Screen, Northstar Origin, and a planned tumor-naive MRD launch by year-end. Management also expects the newly completed Epic Aura integration and expanded sales force to support health-system growth over the next two to four quarters.
• A peer-reviewed study supported Northstar Response’s utility in monitoring immunotherapy, and management expects to pursue MolDX Medicare coverage by year-end. Coverage could improve oncology reimbursement and economics, although the company said future MRD growth may temporarily dilute margins.
• The company held more than $10 million in claims pending in-network implementation by national payers, creating uncertainty around the timing and amount of future collections and contributing to lower quarterly true-up revenue. BillionToOne reiterated its 2026 revenue guidance of $450 million to $465 million and is not including additional true-up revenue in that outlook.

Billiontoone Trading Down 37.0%

Billiontoone stock traded down $55.48 during mid-day trading on Thursday, reaching $94.49. 803,215 shares of the company traded hands, compared to its average volume of 503,602. Billiontoone has a 52-week low of $61.96 and a 52-week high of $150.44. The company has a debt-to-equity ratio of 0.18, a current ratio of 10.92 and a quick ratio of 10.58. The firm’s 50 day moving average price is $116.73 and its 200 day moving average price is $94.26. The firm has a market capitalization of $4.35 billion and a price-to-earnings ratio of 171.80.

Trending Headlines about Billiontoone

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: BTIG Research maintained a Buy rating while lowering its price target from $142 to $130. The revised target still implies approximately 31% upside from the referenced share price, indicating the firm views the recent weakness as a buying opportunity. Benzinga analyst price target report
• Positive Sentiment: BillionToOne reported second-quarter EPS of $0.15, matching Wall Street expectations, and revenue of $109.45 million. The company also reiterated full-year 2026 revenue guidance of $450 million to $465 million, broadly consistent with the $453.3 million analyst consensus. BillionToOne second-quarter 2026 results
• Neutral Sentiment: The earnings release did not provide a clearly positive guidance increase, and the reported quarter met rather than exceeded expectations. With the stock trading at a high valuation, investors may have been looking for a stronger beat or upward revision to forecasts.
• Negative Sentiment: CEO Oguzhan Atay sold a combined 45,000 shares for approximately $6.17 million, reducing his holdings substantially. Although both transactions were executed under a pre-arranged Rule 10b5-1 plan, the size of the sales may weigh on sentiment. SEC filing for CEO stock sales
• Negative Sentiment: Insider Shan Riku Sakakibara separately sold 4,000 shares worth about $561,000. The sale was also pre-arranged, but it adds to a recent pattern of insider selling and may reinforce profit-taking concerns after BLLN’s strong run.
• Negative Sentiment: BTIG’s price-target reduction, despite its continued Buy rating, signals that the firm has moderated its near-term valuation expectations. This is particularly relevant as BillionToOne’s elevated price-to-earnings multiple leaves the stock sensitive to any sign of slowing growth or limited upside revisions.

Insider Transactions at Billiontoone

In other news, CEO Oguzhan Atay sold 32,500 shares of the stock in a transaction that occurred on Monday, August 3rd. The shares were sold at an average price of $136.95, for a total transaction of $4,450,875.00. Following the sale, the chief executive officer owned 20,000 shares in the company, valued at $2,739,000. This represents a 61.90% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shan Riku Sakakibara sold 8,000 shares of the company’s stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $110.00, for a total value of $880,000.00. Following the transaction, the insider directly owned 208,000 shares in the company, valued at approximately $22,880,000. The trade was a 3.70% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 202,049 shares of company stock worth $23,496,861 over the last 90 days. 50.22% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Billiontoone

A number of large investors have recently added to or reduced their stakes in the stock. Massachusetts Financial Services Co. MA bought a new position in shares of Billiontoone during the 4th quarter valued at $13,373,000. Baillie Gifford & Co. purchased a new position in Billiontoone in the fourth quarter worth about $103,786,000. Universal Beteiligungs und Servicegesellschaft mbH bought a new stake in shares of Billiontoone during the 4th quarter valued at about $1,348,000. UBS Group AG purchased a new position in shares of Billiontoone in the fourth quarter worth approximately $2,586,000. Finally, Renaissance Capital LLC bought a new stake in Billiontoone during the fourth quarter valued at approximately $201,000.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on BLLN. JPMorgan Chase & Co. lifted their target price on shares of Billiontoone from $120.00 to $125.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Weiss Ratings upgraded Billiontoone from a “sell (d)” rating to a “sell (d+)” rating in a research report on Tuesday, June 23rd. Guggenheim initiated coverage on Billiontoone in a research note on Monday, June 29th. They issued a “buy” rating and a $125.00 target price for the company. Finally, BTIG Research cut their price objective on shares of Billiontoone from $142.00 to $130.00 and set a “buy” rating for the company in a research report on Thursday. Six analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Billiontoone has an average rating of “Moderate Buy” and a consensus price target of $126.00.

About Billiontoone

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.